TTD | Drug: D0Q2VL

Drug General Information
Drug ID	D0Q2VL
Former ID	DCL000916
Drug Name	PD-157533
Indication	Schizophrenia [ICD9: 295; ICD10:F20]		Preclinical	[536463]
Company	Pfizer
Target and Pathway
Target(s)	D(3) dopamine receptor	Target Info	Antagonist	[536463]
KEGG Pathway	Neuroactive ligand-receptor interaction
KEGG Pathway	Dopaminergic synapse
Reactome	Dopamine receptors
Reactome	G alpha (i) signalling events
WikiPathways	Monoamine GPCRs
	GPCRs, Class A Rhodopsin-like
	GPCR ligand binding
	GPCR downstream signaling
	Nicotine Activity on Dopaminergic Neurons
	GPCRs, Other
References
Ref 536463	The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.
Ref 536463	The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information